Stock Earnings

Question 1

What are China SXT Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), China SXT Pharmaceuticals Inc has a total asset of $21, Net loss of $-3

Question 2

What are the key financial ratios for SXTC?

Accepted Answer

China SXT Pharmaceuticals Inc's Current ratio is 3.5, has a Net margin is -300, sales per share of $0.7.

Question 3

How is China SXT Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

China SXT Pharmaceuticals Inc largest revenue segment is Advanced Traditional Chinese Medicine Pieces, at a revenue of 946,015 in the most earnings release.For geography, China is the primary market for China SXT Pharmaceuticals Inc, at a revenue of 1,928,497.

Question 4

Is China SXT Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, China SXT Pharmaceuticals Inc has a net loss of $-3

Question 5

Does China SXT Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, China SXT Pharmaceuticals Inc has liability of 6

Question 6

How many outstanding shares for China SXT Pharmaceuticals Inc?

Accepted Answer

China SXT Pharmaceuticals Inc has a total outstanding shares of 13.76

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	1	1	1	1	2	4
Revenue Growth (YoY)	0%	0%	0%	-50%	-50%	-20%
Cost of Revenue	1	1	1	1	1	1
Gross Profit	0	0	0	0	1	2
Selling, General & Admin	3	1	2	5	6	5
Research & Development	--	0	--	--	--	--
Operating Expenses	3	2	2	5	6	5
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-3	-3	-3	-5	-5	-2
Income Tax Expense	0	0	0	0	0	0
Net Income	-3	-3	-3	-5	-5	-2
Net Income Growth	0%	0%	-40%	0%	150%	-80%
Shares Outstanding (Diluted)	2.44	1.42	0.1	0.03	0	0
Shares Change (YoY)	1,484%	1,213%	225%	542%	44%	125%
EPS (Diluted)	-1.35	-2.32	-28.57	-177.7	-1,103.84	-763.88
EPS Growth	-93%	-92%	-84%	-84%	45%	-88%
Free Cash Flow	-2	-2	-1	0	0	-1
Free Cash Flow Per Share	-0.81	-1.4	-9.22	0	0	-277.77
Gross Margin	0%	0%	0%	0%	50%	50%
Operating Margin	-200%	-100%	-200%	-500%	-250%	-50%
Profit Margin	-300%	-300%	-300%	-500%	-250%	-50%
Free Cash Flow Margin	-200%	-200%	-100%	0%	0%	-25%
EBITDA	-2	-1	-2	-5	-5	-2
EBITDA Margin	-200%	-100%	-200%	-500%	-250%	-50%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-2	-1	-2	-5	-5	-2
EBIT Margin	-200%	-100%	-200%	-500%	-250%	-50%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

China SXT Pharmaceuticals Inc (SXTC) Price

SXTC Stock Price Chart

SXTC Income

Follow-Up Questions